Guggenheim lowered the firm’s price target on Illumina (ILMN) to $114 from $122 and keeps a Buy rating on the shares. Illumina cut guidance, further derisking from their previous adjusted EPS narrowing in March, notes the analyst, who is lowering the firm’s target to reflect the revised adjusted EPS expectation due to macro uncertainty.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina’s Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges
- Illumina Reports Q1 2025 Financial Results Amid Challenges
- Closing Bell Movers: Pinterest jumps 15%, Toast up 7% after earnings
- Illumina reports Q1 adjusted EPS 97c, consensus 94c
- Illumina cuts FY25 adjusted EPS view to $4.20-$4.30 from $4.50, consensus $4.46